About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
Follow Us
Secure Payments
|
|
|
| Previous Close | $42.23 | Open | |
| Volume | 1.1K | Market Cap | 5.974B |
| Yield | Last Dividend |
| Adaptive Biotechnologies beats forecast ... | 02/25/21 |
| Adaptive Biotechnologies Corp. posted revenue of $30.2 million for the fourth quarter of 2020, up 25% from the corresponding prior year period. The ta... | |
| Adaptive Biotechnologies: Q4 Earnings In... | 02/24/21 |
| Shares of Adaptive Biotechnologies (NASDAQ:ADPT) fell in after-market trading after the company reported Q4 results. Quarterly Results Earnings per sh... | |
| Adaptive Bio Launches T-Cell Based COVID... | 02/23/21 |
| Adaptive Biotechnologies Corp (NASDAQ: ADPT ) launched a clinical T-cell-based test kit to confirm recent or prior COVID-19 infection. T-Detect is cur... | |
| Immune Repertoire Sequencing Market - Th... | 11/26/20 |
| An informative study on the Immune Repertoire Sequencing Market from 2020-2027 has lately released for the database of Coherent Market Insights that h... | |
| Viking Global Investors reduced stake in... | 11/13/20 |
| https://www.investing.com/news/stock-market-news/viking-global-investors-reduced-stake-in-adaptive-biotechnologies-corp-2348133 | |
| Adaptive Biotechnologies, GSK inks MRD t... | 11/11/20 |
| Adaptive Biotechnologies (ADPT +9.3%) has collaborated with GlaxoSmithKline to use its clonoSEQ Assay to assess minimal residual disease (MRD) in GSK'... | |
| Vacasa Appoints Chris Terrill and Chad C... | 11/11/20 |
| PORTLAND, Ore.--(BUSINESS WIRE)--Vacasa, North America???s leading vacation rental management company, has added two tenured executives to its board o... | |
| Here's how 9 leading drugmakers are raci... | 10/27/20 |
| Summary List Placement In the sprint for an effective coronavirus treatment, several of the biggest drugmakers in the world have all landed on the sam... | |
| Sharon Benzeno Sells 417 Shares of Adapt... | 10/22/20 |
| Adaptive Biotechnologies Corporation (NASDAQ:ADPT) insider Sharon Benzeno sold 417 shares of the company???s stock in a transaction that occurred on M... | |
| The Daily Biotech Pulse: J&J Pauses Coro... | 10/13/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 12) 10X... | |
| The Daily Biotech Pulse: Gilead, Lilly C... | 10/08/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-Week Highs Oct. 7) 10X ... | |
| The Daily Biotech Pulse: Eton Snags Seco... | 09/30/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 29) Ac... | |
| Adaptive Biotechnologies to Report Secon... | 07/09/20 |
| SEATTLE, July 09, 2020 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT) a commercial stage biotechnology company that aims to??... | |
| Antibody drugs to prevent and treat the ... | 06/11/20 |
| An antibody therapeutic could land in the sweet spot of the hunt for a coronavirus treatment. Several drug candidates have just started human testing ... | |
| Microsoft and a $5 billion Seattle biote... | 06/11/20 |
| Microsoft and the Seattle biotech Adaptive Biotechnologies have found "blind spots" on the coronavirus that could be good targets for vaccines. The te... | |
| Here's how 13 top drugmakers are sprinti... | 06/08/20 |
| Leading drugmakers are researching treatments and vaccines for the novel coronavirus. The small biotech Moderna has leaped to the front of the race, w... | |
| Microsoft : Adaptive Biotechnologies and... | 05/18/20 |
| LabCorp, through its Covance drug development business, will provide a safe, in-person COVID-19 sample collection service from the convenience of pati... | |
| Stocks making the biggest moves after ho... | 05/12/20 |
| Check out the companies making headlines after the bell. | |
| Is a Surprise Coming for Adaptive Biotec... | 05/11/20 |
| Adaptive Biotechnologies (ADPT) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings se... | |
| LabCorp Announces 2020 First Quarter Res... | 04/29/20 |
| BURLINGTON, N.C.--(BUSINESS WIRE)--LabCorp (or the Company) (NYSE: LH) today announced results for the first quarter ended March 31, 2020. ???First an... | |
| A buzzy Seattle biotech is teaming up wi... | 04/15/20 |
| The Seattle biotech company Adaptive Biotechnologies has started research on a coronavirus therapeutic that could halt the spread of the virus. The sm... | |
| Edited Transcript of ADPT.OQ earnings co... | 04/15/20 |
| Q4 2019 Adaptive Biotechnologies Corp Earnings Call | |
| Amgen : Can Therapeutic Antibodies Offer... | 04/07/20 |
| You may have seen our recent news about the Amgen and Adaptive Biotechnologies strategic partnership to develop a therapeutic to prevent or treat COVI... | |
| The Daily Biotech Pulse: Roche Obtains F... | 03/13/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 12.) ... | |
| The Daily Biotech Pulse: NY State Endors... | 03/11/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 10)... | |
| The Daily Biotech Pulse: Mesoblast To Te... | 03/10/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 9.) A... | |
| The Daily Biotech Pulse: ESMO Conference... | 09/27/19 |
| The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs S... | |
| The Daily Biotech Pulse: Enanta Aces Mid... | 09/26/19 |
| The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs S... | |
| A Viking Global hedge fund is growing it... | 08/20/19 |
| Viking helped data-backup startup Druva Technologies push into unicorn status by leading a $130 million funding round earlier this summer. The $30 bil... | |
| Adaptive Biotechnologies stock down 8.5%... | 08/14/19 |
| Shares of Adaptive Biotechnologies Corp. fell 8.5% in premarket trade Wednesday after the company reported earnings that fell short of analysts' expec... | |
| Hold rating | 03/03/21 |
| Goldman Sachs downgrades from Buy to Neutral rating and lowers Price Target from $74.00 to $63.00 | |
| Hold rating | 02/26/21 |
| Morgan Stanley maintains Equal-Weight rating and raises Price Target from $46.00 to $60.00 | |
| Date | 2021-02-24 (AMC) | Est. (EPS/Rev.) | ($0.29)/ 26.9M |
| Actual (EPS/Rev.) | $-0.33/ $30.19 M | EPS (TTM) | 0 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.